137 related articles for article (PubMed ID: 32916281)
1. Functional analysis of three Na
Solé L; Wagnon JL; Tamkun MM
Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165959. PubMed ID: 32916281
[TBL] [Abstract][Full Text] [Related]
2. SCN8A epileptic encephalopathy mutations display a gain-of-function phenotype and divergent sensitivity to antiepileptic drugs.
Guo QB; Zhan L; Xu HY; Gao ZB; Zheng YM
Acta Pharmacol Sin; 2022 Dec; 43(12):3139-3148. PubMed ID: 35902765
[TBL] [Abstract][Full Text] [Related]
3. Mutations in SCN3A cause early infantile epileptic encephalopathy.
Zaman T; Helbig I; Božović IB; DeBrosse SD; Bergqvist AC; Wallis K; Medne L; Maver A; Peterlin B; Helbig KL; Zhang X; Goldberg EM
Ann Neurol; 2018 Apr; 83(4):703-717. PubMed ID: 29466837
[TBL] [Abstract][Full Text] [Related]
4. Aberrant Sodium Channel Currents and Hyperexcitability of Medial Entorhinal Cortex Neurons in a Mouse Model of
Ottolini M; Barker BS; Gaykema RP; Meisler MH; Patel MK
J Neurosci; 2017 Aug; 37(32):7643-7655. PubMed ID: 28676574
[No Abstract] [Full Text] [Related]
5. Prax330 reduces persistent and resurgent sodium channel currents and neuronal hyperexcitability of subiculum neurons in a mouse model of SCN8A epileptic encephalopathy.
Wengert ER; Saga AU; Panchal PS; Barker BS; Patel MK
Neuropharmacology; 2019 Nov; 158():107699. PubMed ID: 31278928
[TBL] [Abstract][Full Text] [Related]
6. Neuronal hyperexcitability in a mouse model of
Lopez-Santiago LF; Yuan Y; Wagnon JL; Hull JM; Frasier CR; O'Malley HA; Meisler MH; Isom LL
Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2383-2388. PubMed ID: 28193882
[TBL] [Abstract][Full Text] [Related]
7. The SCN8A encephalopathy mutation p.Ile1327Val displays elevated sensitivity to the anticonvulsant phenytoin.
Barker BS; Ottolini M; Wagnon JL; Hollander RM; Meisler MH; Patel MK
Epilepsia; 2016 Sep; 57(9):1458-66. PubMed ID: 27375106
[TBL] [Abstract][Full Text] [Related]
8. A novel de novo mutation of SCN8A (Nav1.6) with enhanced channel activation in a child with epileptic encephalopathy.
Estacion M; O'Brien JE; Conravey A; Hammer MF; Waxman SG; Dib-Hajj SD; Meisler MH
Neurobiol Dis; 2014 Sep; 69():117-23. PubMed ID: 24874546
[TBL] [Abstract][Full Text] [Related]
9. Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications.
Johannesen KM; Liu Y; Koko M; Gjerulfsen CE; Sonnenberg L; Schubert J; Fenger CD; Eltokhi A; Rannap M; Koch NA; Lauxmann S; Krüger J; Kegele J; Canafoglia L; Franceschetti S; Mayer T; Rebstock J; Zacher P; Ruf S; Alber M; Sterbova K; Lassuthová P; Vlckova M; Lemke JR; Platzer K; Krey I; Heine C; Wieczorek D; Kroell-Seger J; Lund C; Klein KM; Au PYB; Rho JM; Ho AW; Masnada S; Veggiotti P; Giordano L; Accorsi P; Hoei-Hansen CE; Striano P; Zara F; Verhelst H; Verhoeven JS; Braakman HMH; van der Zwaag B; Harder AVE; Brilstra E; Pendziwiat M; Lebon S; Vaccarezza M; Le NM; Christensen J; Grønborg S; Scherer SW; Howe J; Fazeli W; Howell KB; Leventer R; Stutterd C; Walsh S; Gerard M; Gerard B; Matricardi S; Bonardi CM; Sartori S; Berger A; Hoffman-Zacharska D; Mastrangelo M; Darra F; Vøllo A; Motazacker MM; Lakeman P; Nizon M; Betzler C; Altuzarra C; Caume R; Roubertie A; Gélisse P; Marini C; Guerrini R; Bilan F; Tibussek D; Koch-Hogrebe M; Perry MS; Ichikawa S; Dadali E; Sharkov A; Mishina I; Abramov M; Kanivets I; Korostelev S; Kutsev S; Wain KE; Eisenhauer N; Wagner M; Savatt JM; Müller-Schlüter K; Bassan H; Borovikov A; Nassogne MC; Destrée A; Schoonjans AS; Meuwissen M; Buzatu M; Jansen A; Scalais E; Srivastava S; Tan WH; Olson HE; Loddenkemper T; Poduri A; Helbig KL; Helbig I; Fitzgerald MP; Goldberg EM; Roser T; Borggraefe I; Brünger T; May P; Lal D; Lederer D; Rubboli G; Heyne HO; Lesca G; Hedrich UBS; Benda J; Gardella E; Lerche H; Møller RS
Brain; 2022 Sep; 145(9):2991-3009. PubMed ID: 34431999
[TBL] [Abstract][Full Text] [Related]
10. Distinct functional alterations in SCN8A epilepsy mutant channels.
Pan Y; Cummins TR
J Physiol; 2020 Jan; 598(2):381-401. PubMed ID: 31715021
[TBL] [Abstract][Full Text] [Related]
11. R1617Q epilepsy mutation slows Na
Poulin H; Chahine M
J Physiol; 2021 Mar; 599(5):1651-1664. PubMed ID: 33442870
[TBL] [Abstract][Full Text] [Related]
12. Complex biophysical changes and reduced neuronal firing in an SCN8A variant associated with developmental delay and epilepsy.
Quinn S; Zhang N; Fenton TA; Brusel M; Muruganandam P; Peleg Y; Giladi M; Haitin Y; Lerche H; Bassan H; Liu Y; Ben-Shalom R; Rubinstein M
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167127. PubMed ID: 38519006
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin-Positive Interneurons Contribute to Seizures in
Wengert ER; Miralles RM; Wedgwood KCA; Wagley PK; Strohm SM; Panchal PS; Idrissi AM; Wenker IC; Thompson JA; Gaykema RP; Patel MK
J Neurosci; 2021 Nov; 41(44):9257-9273. PubMed ID: 34544834
[No Abstract] [Full Text] [Related]
14. Characterization of a de novo SCN8A mutation in a patient with epileptic encephalopathy.
de Kovel CG; Meisler MH; Brilstra EH; van Berkestijn FM; van 't Slot R; van Lieshout S; Nijman IJ; O'Brien JE; Hammer MF; Estacion M; Waxman SG; Dib-Hajj SD; Koeleman BP
Epilepsy Res; 2014 Nov; 108(9):1511-8. PubMed ID: 25239001
[TBL] [Abstract][Full Text] [Related]
15. Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol.
Patel RR; Barbosa C; Brustovetsky T; Brustovetsky N; Cummins TR
Brain; 2016 Aug; 139(Pt 8):2164-81. PubMed ID: 27267376
[TBL] [Abstract][Full Text] [Related]
16. Neuronal mechanisms of mutations in SCN8A causing epilepsy or intellectual disability.
Liu Y; Schubert J; Sonnenberg L; Helbig KL; Hoei-Hansen CE; Koko M; Rannap M; Lauxmann S; Huq M; Schneider MC; Johannesen KM; Kurlemann G; Gardella E; Becker F; Weber YG; Benda J; Møller RS; Lerche H
Brain; 2019 Feb; 142(2):376-390. PubMed ID: 30615093
[TBL] [Abstract][Full Text] [Related]
17. Single amino acid deletion in transmembrane segment D4S6 of sodium channel Scn8a (Nav1.6) in a mouse mutant with a chronic movement disorder.
Jones JM; Dionne L; Dell'Orco J; Parent R; Krueger JN; Cheng X; Dib-Hajj SD; Bunton-Stasyshyn RK; Sharkey LM; Dowling JJ; Murphy GG; Shakkottai VG; Shrager P; Meisler MH
Neurobiol Dis; 2016 May; 89():36-45. PubMed ID: 26807988
[TBL] [Abstract][Full Text] [Related]
18. De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy.
Blanchard MG; Willemsen MH; Walker JB; Dib-Hajj SD; Waxman SG; Jongmans MC; Kleefstra T; van de Warrenburg BP; Praamstra P; Nicolai J; Yntema HG; Bindels RJ; Meisler MH; Kamsteeg EJ
J Med Genet; 2015 May; 52(5):330-7. PubMed ID: 25725044
[TBL] [Abstract][Full Text] [Related]
19. Variable patterns of mutation density among NaV1.1, NaV1.2 and NaV1.6 point to channel-specific functional differences associated with childhood epilepsy.
Encinas AC; Watkins JC; Longoria IA; Johnson JP; Hammer MF
PLoS One; 2020; 15(8):e0238121. PubMed ID: 32845893
[TBL] [Abstract][Full Text] [Related]
20. The novel sodium channel modulator GS-458967 (GS967) is an effective treatment in a mouse model of SCN8A encephalopathy.
Baker EM; Thompson CH; Hawkins NA; Wagnon JL; Wengert ER; Patel MK; George AL; Meisler MH; Kearney JA
Epilepsia; 2018 Jun; 59(6):1166-1176. PubMed ID: 29782051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
